An insidious increase in features of the zzso zzso zzso zzso insulin resistance and zzso zzso has zzso to produce a worldwide epidemic of type 2 zzso diabetes zzso Most current therapies for this disease were developed in the absence of defined molecular targets or an understanding of disease zzso Emerging knowledge of key pathogenic zzso such as the impairment of zzso insulin secretion and the role of zzso as a probable cause of hepatic and muscle resistance to zzso effects on glucose zzso has led to a host of new molecular drug zzso Several have been validated through genetic engineering in mice or the preliminary use of lead compounds and therapeutic agents in animals and zzso 
